Histologic transformation from adenocarcinoma to both small cell lung cancer and squamous cell carcinoma after treatment with gefitinib: A case report

RATIONALE: In the past decade, epidermal growth factor receptor (EGFR) tyrosine kinase inhibitors (TKIs) treatment had been an important therapy for treating advanced EGFR-mutated lung cancer patients. However, a large number of these patients with EGFR-TKIs treatment always acquired resistance to t...

Descripción completa

Detalles Bibliográficos
Autores principales: Yao, Yufeng, Zhu, Zhouyu, Wu, Yimin, Chai, Ying
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Wolters Kluwer Health 2018
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6393132/
https://www.ncbi.nlm.nih.gov/pubmed/29718881
http://dx.doi.org/10.1097/MD.0000000000010650

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6393132/
https://www.ncbi.nlm.nih.gov/pubmed/29718881
http://dx.doi.org/10.1097/MD.0000000000010650

Ejemplares similares